Tugce Karaderi

Tugce Karaderi is an Associate Professor in the Department of Public Health at the University of Copenhagen, specifically affiliated with the Section for Health Data Science and AI. She maintains an active research profile with significant contributions to genetic epidemiology and translational data science.

• University of Copenhagen, Faculty of Health and Medical Sciences
• Department of Public Health, Section for Health Data Science and AI
• ORCID: 0000-0001-9763-8139

Dr. Karaderi's educational background includes a DPhil in Human Genetics from the University of Oxford (focusing on the genetics of Ankylosing Spondylitis), an MSc in Environmental Health from the Cyprus Institute for the Environment and Public Health in association with Harvard School of Public Health, and a BSc in Biology from the University of Missouri at Kansas City.

Her research spans multiple areas of genomic medicine, with particular emphasis on polygenic risk prediction, multi-omics integration for complex diseases, and AI applications in personalized medicine. She has made significant contributions to understanding the genetic architecture of obesity, polycystic ovary syndrome, and thyroid disorders through large-scale international collaborations. Her work often involves multi-ancestry analyses to ensure broader applicability of findings across diverse populations.

Analysis of her recent publications reveals a consistent focus on translating genomic discoveries into clinical applications, with particular attention to sex-specific differences in disease presentation and response. Her research methodology integrates statistical genetics with machine learning approaches to extract meaningful insights from complex biological datasets.

Dr. Karaderi has contributed to numerous high-impact publications in journals including Nature, Nature Medicine, Nature Communications, and Diabetes, often as part of major international consortia. Her work has been widely disseminated through social media and picked up by multiple news outlets, demonstrating its relevance to both scientific and public audiences.

Her research program demonstrates strong collaborative networks across multiple institutions and countries, reflecting the increasingly international nature of genomic research. She appears to be actively involved in both basic science investigations and translational applications of genomic discoveries to improve patient care.